- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00138840
Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, for the Induction of Clinical Response in Patients With Crohn's Disease
STA-5326 is an experimental drug that has been shown to block the release of interleukin-12 from peripheral blood mononuclear cells. Given this activity on the immune system, STA-5326 mesylate is a potential treatment for various autoimmune diseases, such as Crohn's disease, that are mediated by the inappropriate expression of Th1 cytokines.
This study is evaluating the use of STA-5326 mesylate in patients with moderate to severe, active Crohn's disease. Study visits include a screening visit, 9 treatment period visits over 6 months and a follow-up visit that will occur 30 days following the end of treatment. Study drug treatment will continue for up to 6 months.
Panoramica dello studio
Tipo di studio
Iscrizione
Fase
- Fase 2
Contatti e Sedi
Luoghi di studio
-
-
Alberta
-
Calgary, Alberta, Canada, T2N4N1
- University of Calgary Health Sciences
-
-
Ontario
-
London, Ontario, Canada, N6A 4G5
- London Health Science Center South Street Campus
-
London, Ontario, Canada, N6A 5A5
- London Health Science Center University Campus
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Canada, S7K1N4
- Saskatoon Medical Specialists
-
-
-
-
Arkansas
-
Little Rock, Arkansas, Stati Uniti, 72205
- Gastroenterology Associates
-
-
California
-
Anaheim, California, Stati Uniti, 92801
- Advanced Clinical Research Institute
-
Orange, California, Stati Uniti, 92868
- Community Clinical Trials
-
San Diego, California, Stati Uniti, 92123
- Medical Associates Research Group
-
-
Florida
-
Hollywood, Florida, Stati Uniti, 33021
- Southern Clinical Research Consultants
-
Jacksonville, Florida, Stati Uniti, 32204
- Borland Groover Clinic
-
Miami, Florida, Stati Uniti, 33173
- Miami Research Associates
-
Palm Harbor, Florida, Stati Uniti, 34684
- Advanced Gastroenterology Highland Lakes Medical Center
-
Winter Park, Florida, Stati Uniti, 32789
- Shafran Gastroenterology Center
-
-
Georgia
-
Atlanta, Georgia, Stati Uniti, 30342
- Atlanta Gastroenterology
-
-
Kentucky
-
Louisville, Kentucky, Stati Uniti, 40202
- Univ. of Louisville Clinical Research Unit
-
-
Maryland
-
Chevy Chase, Maryland, Stati Uniti, 20815
- Chevy Chase Clinical Research
-
Laurel, Maryland, Stati Uniti, 20707
- Maryland Digestive Disease Research
-
Silver Spring, Maryland, Stati Uniti, 20901
- Capital Gastroenterology Consultants, P.A.
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02118
- Boston Medical Center
-
-
Missouri
-
St. Louis, Missouri, Stati Uniti, 63128
- St. Louis Center for Clinical Research
-
-
New Jersey
-
Cedar Knolls, New Jersey, Stati Uniti, 07927
- Gastroenterology Research Associates
-
-
New York
-
New York, New York, Stati Uniti, 10128
- Asher Kornbluth, MD
-
Rochester, New York, Stati Uniti, 14607
- Rochester Institute for Digestive Diseases and Sciences, Inc.
-
-
North Carolina
-
Asheville, North Carolina, Stati Uniti, 28801
- Asheville Gastroenterology Associates, PA
-
Charlotte, North Carolina, Stati Uniti, 28211
- Carolina Digestive Health Associates
-
Pinehurst, North Carolina, Stati Uniti, 28374
- Pinehurst Medical Clinic
-
Raleigh, North Carolina, Stati Uniti, 27612
- Wake Research Associates, LLC.
-
Winston-Salem, North Carolina, Stati Uniti, 27103
- Piedmont Medical Research Associates
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Stati Uniti, 15213
- University of Pittsburgh
-
-
South Carolina
-
Columbia, South Carolina, Stati Uniti, 29203
- Columbia Gastroenterology Associates, P.A.
-
-
Tennessee
-
German Town, Tennessee, Stati Uniti, 38138
- Gastroenterology Center of the Midsouth
-
Nashville, Tennessee, Stati Uniti, 37205
- Nashville Medical Research Institute
-
-
Texas
-
Austin, Texas, Stati Uniti, 78745
- Austin Gastroenterology
-
-
Virginia
-
Christiansburg, Virginia, Stati Uniti, 24073
- New River Valley Research Institute
-
-
Wisconsin
-
Milwaukee, Wisconsin, Stati Uniti, 53215
- Wisconsin Center for Advanced Research
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Is male or female aged 18 through 75 years.
- Has Crohn's disease diagnosed definitively prior to Screening (based upon clinical, endoscopic, radiologic imaging, or histological assessments).
- Has a Crohn's Disease Activity Index (CDAI) score of 220 to 450, inclusive at Baseline.
Exclusion Criteria:
- Has any clinically significant disease (eg, renal, hepatic, neurological, cardiovascular, pulmonary, endocrinologic, psychiatric, hematologic, urologic, or other acute or chronic illness) that, in the opinion of the investigator, would make the patient an unsuitable candidate for this study.
- Is a woman who has a positive pregnancy test, who is breast-feeding, or who is sexually active without using birth control during the course of the study and Follow-Up period.
- Is a woman of childbearing potential or a man who does not agree to use 2 forms of contraception during the course of the study and Follow-Up period.
- Has clinically significant hematologic, hepatic or renal laboratory abnormalities.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
---|
Proportion of patients achieving clinical remission and clinical response at Day 29
|
Misure di risultato secondarie
Misura del risultato |
---|
Proportion of patients achieving: a clinical remission at Days 29 and 43
|
a clinical response from Baseline to Day 29 and from Baseline to Day 43
|
a reduction in endoscopic scores from Baseline to Day 29
|
an increase in the Inflammatory Bowel Disease Questionnaire (IBDQ) score from Baseline to Days 29 and 43
|
a clinical remission or clinical response at Days 29 and 43 in the subset of patients with elevated C-reactive protein
|
Collaboratori e investigatori
Sponsor
Investigatori
- Bruce Sands, MD, Massachusetts General Hospital
Studiare le date dei record
Studia le date principali
Inizio studio
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 5326-07
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su STA-5326 mesilato
-
Synta Pharmaceuticals Corp.Completato
-
National Institute of Allergy and Infectious Diseases...CompletatoMorbo di CrohnStati Uniti
-
Genzyme, a Sanofi CompanyCompletato
-
National Institute of Allergy and Infectious Diseases...CompletatoImmunodeficienza variabile comuneStati Uniti
-
Synta Pharmaceuticals Corp.National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...CompletatoMorbo di CrohnStati Uniti
-
Genzyme, a Sanofi CompanyTerminatoMalattia di CrohnIsraele, Stati Uniti, Romania, Ucraina, Sud Africa, Canada, Australia, Bulgaria, Federazione Russa, Nuova Zelanda, Brasile
-
Genzyme, a Sanofi CompanyTerminato
-
Genzyme, a Sanofi CompanyTerminatoMalattia di CrohnSvizzera, Stati Uniti, Nuova Zelanda, Canada, Australia, Brasile, Regno Unito, Ucraina, Federazione Russa, Argentina
-
Genzyme, a Sanofi CompanyTerminato
-
Genzyme, a Sanofi CompanyTerminatoMalattia di CrohnStati Uniti